Ginkgo Bioworks and Amyris have formed a new partnership, enabling both companies to work together developing products. As a result, the companies will be joining R&D capabilities.
Ginkgo will broaden Amyris's strain engineering capacity by providing access to its foundry, while Amyris will allow Ginkgo access to its commercial scale multi-product fermentation facility.
“Ginkgo and Amyris working together sets the gold standard for the industrial biotechnology industry,” said Jason Kelly, CEO of Ginkgo Bioworks. “Each company is seeing more customer demand for cultured ingredient partnerships than could be handled individually. By sharing our assets, expertise and experience we can offer more customers access to the industry-leading technology platform.”